Down syndrome

Down syndrome
Vanellus Foto · CC BY-SA 3.0 · source
Name	Down syndrome

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21 that produces a characteristic pattern of physical features, developmental differences, and medical comorbidities. It has been described in historical records and studied in modern Genetics, with extensive clinical literature from institutions such as Mayo Clinic, Johns Hopkins Hospital, Great Ormond Street Hospital and public health agencies including the World Health Organization, Centers for Disease Control and Prevention and National Institutes of Health. Individuals with the condition participate in communities, professions and cultural life evident in organizations like Special Olympics, United Nations, Paralympic Games and advocacy groups such as National Down Syndrome Society, Down's Syndrome Association (UK), Global Down Syndrome Foundation.

Signs and symptoms

Common physical signs include distinct craniofacial features, hypotonia, single transverse palmar crease and brachycephaly; clinical descriptions appear in literature from Guy's Hospital, Great Ormond Street Hospital, Boston Children's Hospital and historical texts from Royal Society, Lancet and New England Journal of Medicine. Developmental differences often include delayed motor milestones, speech and language delays, and variable intellectual disability documented by practitioners at Harvard Medical School, Stanford University, University of Oxford and specialists publishing in American Academy of Pediatrics. Medical comorbidities include congenital heart defects (atrioventricular septal defect, ventricular septal defect) treated in centers such as Cleveland Clinic, Boston Children's Hospital, Great Ormond Street Hospital and monitored by guidelines from American Heart Association, European Society of Cardiology, National Institute for Health and Care Excellence. Other issues—endocrine disorders including hypothyroidism, hematologic conditions such as transient myeloproliferative disorder and acute lymphoblastic leukemia, ophthalmologic problems (strabismus, refractive errors) and otolaryngologic concerns (hearing loss, recurrent otitis media)—are managed in multidisciplinary teams at Mayo Clinic, Johns Hopkins Hospital, Great Ormond Street Hospital and referenced in journals like Pediatrics, The Lancet Child & Adolescent Health.

Causes and genetics

The condition results from trisomy of chromosome 21 due to nondisjunction, Robertsonian translocation or mosaicism; cytogenetic mechanisms were characterized by researchers at Cambridge University, Columbia University, MRC Laboratory of Molecular Biology and reported in publications from Science and Nature Genetics. Maternal age is a well-established risk factor cited in demographic studies from United Kingdom, United States, Japan and Sweden, while paternal age and environmental exposures have more limited and contested associations explored by teams at NIH, Karolinska Institutet, University of Toronto and University of Washington. Molecular testing techniques—karyotyping, fluorescence in situ hybridization and chromosomal microarray—were developed in laboratories at Cold Spring Harbor Laboratory, Broad Institute, Wellcome Trust Sanger Institute and are implemented in clinical genetics services at Great Ormond Street Hospital, John Radcliffe Hospital and major academic centers.

Diagnosis

Prenatal screening methods include first-trimester combined screening (nuchal translucency with serum markers), cell-free fetal DNA testing developed by companies and groups linked to Illumina, Roche, Ariosa Diagnostics and confirmatory invasive tests (chorionic villus sampling, amniocentesis) performed in clinics affiliated with Mount Sinai Health System, UCLA Health and Massachusetts General Hospital. Newborn diagnosis is often suspected clinically and confirmed by karyotype or rapid aneuploidy testing in neonatal units at Boston Children's Hospital, Royal Children's Hospital (Melbourne), SickKids Hospital and reported through registries coordinated with CDC surveillance programs. Ethical, legal and counseling aspects of testing involve professional societies such as American College of Medical Genetics and Genomics, Royal College of Obstetricians and Gynaecologists and advocacy input from Down's Syndrome Association (UK), National Down Syndrome Congress.

Management and treatment

Management is multidisciplinary, often coordinated through pediatric clinics, cardiology, endocrinology, audiology, ophthalmology, speech therapy, occupational therapy and community services from organizations like Early Intervention Program (US), National Health Service (UK), Medicare (Australia) and clinics at Johns Hopkins Hospital or Great Ormond Street Hospital. Cardiac defects may require surgical correction at centers such as Cleveland Clinic and Great Ormond Street Hospital with perioperative guidelines by American Heart Association; hematologic and oncologic care follows protocols from Children's Oncology Group and European Society for Paediatric Oncology. Educational interventions and behavioral therapies informed by research at University of Cambridge, University of Oxford, Columbia University Teachers College and special education programs run by local authorities and charities such as Special Olympics and The Arc support adaptive skills and inclusion.

Epidemiology and prognosis

Prevalence varies by region and maternal age with surveillance data from CDC, Eurocat, Australia Institute of Health and Welfare and national registries in Denmark, Iceland and Finland; contemporary prevalence estimates range around 1 in 700 to 1 in 1,000 live births in many populations, with variations reported in studies published in BMJ, The Lancet and JAMA. Life expectancy has increased substantially since mid-20th century owing to advances in cardiac surgery, infection control and healthcare systems at institutions like Mayo Clinic and Cleveland Clinic, with population studies from United Kingdom and United States documenting median ages rising into the 60s in some cohorts. Morbidity and mortality patterns include early-life cardiac and respiratory issues and later-life risks such as Alzheimer-type dementia associated with gene dosage effects on chromosome 21; longitudinal research from Alzheimer's Association, University of California, San Francisco, University of Cambridge informs prognosis and care planning.

Social aspects and advocacy

Advocacy, policy and cultural representation involve organizations such as National Down Syndrome Society, Global Down Syndrome Foundation, Down's Syndrome Association (UK), Special Olympics and civil society groups active in United Nations human rights discussions and disability rights initiatives referencing instruments like the United Nations Convention on the Rights of Persons with Disabilities. Employment, education and independent living supports are promoted by agencies including Department for Work and Pensions (UK), Social Security Administration (US), American Association on Intellectual and Developmental Disabilities and charities such as The Arc and Inclusion International. Prominent public figures and artists with the condition and allies have appeared in media and cultural institutions like BBC, PBS, TIME (magazine) and The New York Times, contributing to visibility, research funding and policy change championed by foundations such as Bill & Melinda Gates Foundation and Kaiser Family Foundation.

Category:Genetic disorders